retevmo 40 mg
eli lilly israel ltd, israel - selpercatinib - capsules - selpercatinib 40 mg - selpercatinib - • metastatic ret fusion-positive non-small cell lung cancerretevmo™ is indicated for the treatment of adult patients with metastatic ret fusion-positive non-small cell lung cancer (nsclc).• ret-mutant medullary thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret-mutant medullary thyroid cancer (mtc) who require systemic therapy.• ret fusion-positive thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).
retevmo 80 mg
eli lilly israel ltd, israel - selpercatinib - capsules - selpercatinib 80 mg - selpercatinib - • metastatic ret fusion-positive non-small cell lung cancerretevmo™ is indicated for the treatment of adult patients with metastatic ret fusion-positive non-small cell lung cancer (nsclc).• ret-mutant medullary thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret-mutant medullary thyroid cancer (mtc) who require systemic therapy.• ret fusion-positive thyroid cancerretevmo is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic ret fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).
epilim liquid sodium valproate 40 mg/ml sugar free oral liquid bottle
sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: purified water; sorbitol solution (70 per cent) (non-crystallising); sodium methyl hydroxybenzoate; citric acid; brilliant scarlet 4r; hyetellose; sodium propyl hydroxybenzoate; saccharin sodium; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate
epilim sodium valproate 100mg crushable tablet blister pack
sanofi-aventis australia pty ltd - sodium valproate, quantity: 100 mg - tablet, uncoated - excipient ingredients: magnesium stearate; silicon dioxide; kaolin; maize starch - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate
atenolol actavis
teva pharma (new zealand) limited - atenolol 100mg - tablet - 100 mg - active: atenolol 100mg excipient: gelatin heavy magnesium carbonate magnesium stearate maize starch microcrystalline cellulose purified talc sodium laurilsulfate - management of hypertension
atehexal
novartis new zealand ltd - atenolol 100mg - film coated tablet - 100 mg - active: atenolol 100mg excipient: gelatin heavy magnesium carbonate hypromellose magnesium stearate maize starch propylene glycol sodium laurilsulfate
house dust extract
trupharm marketing 1985 ltd. - dust extract - solution for injection - dust extract - allergen extracts - skin testing and immunotherapy.
trandate injection 100 mg20 ml
dch auriga singapore - labetalol hcl - injection - 100 mg/20 ml - labetalol hcl 100 mg/20 ml
allergy canada allergen extract - alum precipitated liquid
allergy canada ltd - allergen extract - alum precipitated - liquid - 10000unit - allergen extract - alum precipitated 10000unit - allergenic extracts
allergy canada allergen extract liquid
allergy canada ltd - allergenic extracts - liquid - 0unit - allergenic extracts 0unit - allergenic extracts